Form D — Amlogenyx Inc.
0001231919-26-000740 · filed Jul 9, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $20,000,000
- Reported amount sold
- $10,000,000
- Minimum investment
- $0
- Investors
- 2
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Amlogenyx Inc.
- CIK
- 2031988
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 77 DIGITAL DRIVE, SUITE 200
NOVATO, CA 94949 - Phone
- 415-483-8800
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
TED HUIZENGA · Executive OfficerNOVATO, CA Find on LinkedIn ↗
-
JOHN PINION · Executive OfficerNOVATO, CA Find on LinkedIn ↗
-
CRAIG GORDON · DirectorNOVATO, CA Find on LinkedIn ↗
-
EMIL KAKKIS · Executive OfficerNOVATO, CA Find on LinkedIn ↗
-
SUKUMAR NAGENDRAN · DirectorNOVATO, CA Find on LinkedIn ↗
-
Karah Parschauer · Executive OfficerNOVATO, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗